Fig. 6From: Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitroIC50 isobolograms for cytochalasin B, 21, 22-dihydrocytochalasin B, doxorubicin, and paclitaxel against SKOV3 and SKVLB1 human ovarian carcinoma. a CB and ADR. b CB and Tax. c DiHCB and ADR. d DiHCB and Tax. IC50 values were determined after a 48Â h continuous exposureBack to article page